Research presented at AAAAI 2026 found that 88% of participants preferred intranasal epinephrine over injectables.
Douglas P. Mack
Advertisement
Douglas P. Mack, a pediatric allergist and assistant clinical professor at McMaster University
Articles by Douglas P. Mack
A randomized crossover study shows that most patients prefer intranasal epinephrine for anaphylaxis due to its ease of use, portability, and the absence of needles.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
2
Diabetes Technology at a Turning Point: What’s New and What’s Next, With Rachael Sood, NP
3
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
4
Brief, Regular Movement Breaks Can Improve Cardiovascular Risk in T2D
5